Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kaili Catalyst & New Materials Co.,Ltd. (688269.SS)
Xi'an, SH, CN
Kaili Catalyst & New Materials Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of precious metal catalysts in China and internationally. The company offers palladium, platinum, rhodium, ruthenium, and iridium series of catalysts. It also engages in research and development of catalytic application technology, and the recycling and reprocessing of waste precious metals catalysts. The company’s products are used in medicines, pesticides, dyes, pigments, paints, liquid crystal materials, electronic materials, petrochemicals, and other sectors. The company was formerly known as Xi'an Kaili Chemical Co., Ltd. Kaili Catalyst & New Materials Co.,Ltd. was founded in 1980 and is based in Xi'an, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Specialty Business Services: +7.6%+20.6% ★ Q1'26: +20.6% (vs Q1'25)
-
EPS growth Specialty Business Services: +24.4%+18.3% Q1'26: +117.6% (vs Q1'25)
-
FCF margin FCF growth · Specialty Business Services: +27.6%+6.6% ★ Q1'26: -59.1% (vs Q1'25)
-
EBIT margin Specialty Business Services: +9.0%+5.9% Q1'26: +6.6% (vs Q1'25)
-
ROIC Specialty Business Services: +7.8%— Q1'26: +8.7% (vs Q1'25)
-
Share dilution Specialty Business Services: +0.4%+0.7% Q1'26: +1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Specialty Business Services: -0.21×— Q1'26: 5.38× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
1.59B
est: 1.49B (+6.9%)
|
1.88B
est: 2.05B (-8.2%)
|
1.79B
est: 1.81B (-1.1%)
|
1.69B
est: 1.73B (-2.7%)
|
2.03B
est: 2.18B (-6.8%)
|
2.59B
2.59B – 2.59B
+18.8% YoY
|
3.31B
3.31B – 3.31B
+27.7% YoY
|
| EBITDA |
194.59M
est: 161.07M (+20.8%)
|
258.54M
est: 222.11M (+16.4%)
|
139.85M
est: 195.62M (-28.5%)
|
135.04M
est: 187.72M (-28.1%)
|
144.38M
est: 236.46M (-38.9%)
|
280.87M
280.87M – 280.87M
+18.8% YoY
|
358.59M
358.59M – 358.59M
+27.7% YoY
|
| EBIT |
190.65M
est: 152.17M (+25.3%)
|
253.63M
est: 209.84M (+20.9%)
|
128.82M
est: 184.82M (-30.3%)
|
110.89M
est: 177.35M (-37.5%)
|
120.23M
est: 223.40M (-46.2%)
|
265.35M
265.35M – 265.35M
+18.8% YoY
|
338.79M
338.79M – 338.79M
+27.7% YoY
|
| Net Income |
162.56M
est: 169.58M (-4.1%)
|
221.11M
est: 231.54M (-4.5%)
|
112.88M
est: 128.27M (-12.0%)
|
92.62M
est: 105.04M (-11.8%)
|
110.29M
est: 136.55M (-19.2%)
|
214.01M
214.01M – 214.01M
+56.7% YoY
|
386.00M
386.00M – 386.00M
+80.4% YoY
|
| SGA |
31.63M
est: 13.92M (+127.2%)
|
31.60M
est: 19.20M (+64.6%)
|
33.82M
est: 16.91M (+100.0%)
|
45.40M
est: 16.22M (+179.8%)
|
—
est: 20.44M (-100.0%)
|
24.28M
24.28M – 24.28M
+18.8% YoY
|
30.99M
30.99M – 30.99M
+27.7% YoY
|
| EPS |
1.42
est: 1.30 (+9.2%)
|
1.69
est: 1.78 (-4.8%)
|
0.86
est: 0.98 (-12.5%)
|
0.71
est: 0.80 (-11.3%)
|
0.84
est: 1.04 (-19.2%)
|
1.63
1.63 – 1.63
+56.7% YoY
|
2.94
2.94 – 2.94
+80.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Baiye Zhu | Deputy General Manager | — | male |
| Bo Mou | Deputy General Manager | — | male |
| Kerou Wan | GM & Director | — | male |
| Shihong Wang | Chief Financial Officer & Secretary to the Board of Directors | — | female |
| Xiaopeng Sun | Accounting Supervisor | — | — |
| Yuefeng Li | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 688269.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
